Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
management to meet virtually with Piper Sandler » 06:17
05/31/23
05/31
06:17
05/31/23
06:17
DEI

Douglas Emmett

$11.72 /

+0.38 (+3.35%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 19:40:37

Get Free Trial

ShowHide Related Items >><<
DEI Douglas Emmett
$11.72 /

+0.38 (+3.35%)

DEI Douglas Emmett
$11.72 /

+0.38 (+3.35%)

04/05/23 Piper Sandler
Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler
03/30/23 BMO Capital
Douglas Emmett price target lowered to $12 from $14 at BMO Capital
03/29/23 BMO Capital
Douglas Emmett price target lowered to $12 from $13 at BMO Capital
03/27/23 Evercore ISI
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
DEI Douglas Emmett
$11.72 /

+0.38 (+3.35%)

DEI Douglas Emmett
$11.72 /

+0.38 (+3.35%)

Over a month ago
Earnings
Douglas Emmett backs FY23 FFO view $1.87-$1.93, consensus $1.91 » 16:28
05/02/23
05/02
16:28
05/02/23
16:28
DEI

Douglas Emmett

$12.17 /

-0.46 (-3.64%)

The company said,…

The company said, "We are adjusting our assumption for average office occupancy, which we now expect to be between 81% and 83% for the year. As a result, we adjusted our expected range of same property cash NOI growth to be between -1.5% and -0.5%, and for straight-line revenue to be between $1 million and $3 million. These adjustments are offset by the benefit of our stock repurchase so our guidance range for full year FFO per fully diluted share remains between $1.87 and $1.93. We expect Net Income Per Common Share - Diluted to be between $0.35 and $0.41. Our guidance does not include the impact of future property acquisitions or dispositions, stock sales or repurchases, financings, property damage insurance recoveries, impairment charges or other possible capital markets activities."

ShowHide Related Items >><<
DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

04/05/23 Piper Sandler
Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler
03/30/23 BMO Capital
Douglas Emmett price target lowered to $12 from $14 at BMO Capital
03/29/23 BMO Capital
Douglas Emmett price target lowered to $12 from $13 at BMO Capital
03/27/23 Evercore ISI
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

Earnings
Douglas Emmett reports Q1 FFO 47c, consensus 48c » 16:27
05/02/23
05/02
16:27
05/02/23
16:27
DEI

Douglas Emmett

$12.17 /

-0.46 (-3.64%)

"During the first…

"During the first quarter, we signed 235 office leases covering approximately 625,000 square feet, including 168,000 square feet of new leases," the company said. "The slowdown in the leasing pipeline that we mentioned on our last call resulted in a decline in our leased rate, even though we actually signed more leases in the quarter than usual. We continue to have strong demand from tenants under 10,000 square feet, who dominate our markets. But because larger tenants have become more conservative in response to recessionary concerns, we leased less total square footage. Comparing the office leases we signed during the first quarter to the expiring leases for the same space, straight-line rents increased by 6.0% and cash rents decreased by 6.7%. Our multifamily portfolio remains essentially fully leased at 99.3%."

ShowHide Related Items >><<
DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

04/05/23 Piper Sandler
Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler
03/30/23 BMO Capital
Douglas Emmett price target lowered to $12 from $14 at BMO Capital
03/29/23 BMO Capital
Douglas Emmett price target lowered to $12 from $13 at BMO Capital
03/27/23 Evercore ISI
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

DEI Douglas Emmett
$12.17 /

-0.46 (-3.64%)

Upgrade
Douglas Emmett upgraded to Overweight from Neutral at Piper Sandler » 05:10
04/05/23
04/05
05:10
04/05/23
05:10
DEI

Douglas Emmett

$12.26 /

+0.01 (+0.08%)

Piper Sandler analyst…

Piper Sandler analyst Alexander Goldfarb upgraded Douglas Emmett to Overweight from Neutral with a price target of $15, up from $13. The company's implied cap rate of 11.5% and 70% discount to net asset value are "way too wide," the analyst tells investors in a research note. Douglas Emmett's core small tenants remain active, while its multifamily deliveries are exceeding pro forma, says the firm.

ShowHide Related Items >><<
DEI Douglas Emmett
$12.26 /

+0.01 (+0.08%)

DEI Douglas Emmett
$12.26 /

+0.01 (+0.08%)

03/30/23 BMO Capital
Douglas Emmett price target lowered to $12 from $14 at BMO Capital
03/29/23 BMO Capital
Douglas Emmett price target lowered to $12 from $13 at BMO Capital
03/27/23 Evercore ISI
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
03/21/23 Piper Sandler
Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
DEI Douglas Emmett
$12.26 /

+0.01 (+0.08%)

DEI Douglas Emmett
$12.26 /

+0.01 (+0.08%)

Recommendations
Douglas Emmett price target lowered to $12 from $14 at BMO Capital » 07:29
03/30/23
03/30
07:29
03/30/23
07:29
DEI

Douglas Emmett

$12.06 /

+0.485 (+4.19%)

BMO Capital lowered the…

BMO Capital lowered the firm's price target on Douglas Emmett to $12 from $14 and keeps an Underperform rating on the shares. The company has the land to more than double its multifamily portfolio in LA and Hawaii over time, but with the likely departure of its largest tenant, Warner Bros Discovery, in Burbank next year, the firm is reducing its 2024 occupancy assumptions and 2024 estimates, the analyst tells investors in a research note. The stock is inexpensive and risks of default are low, BMO adds, though cutting its FY24 FFO view by 5c to $1.77.

ShowHide Related Items >><<
DEI Douglas Emmett
$12.06 /

+0.485 (+4.19%)

DEI Douglas Emmett
$12.06 /

+0.485 (+4.19%)

03/29/23 BMO Capital
Douglas Emmett price target lowered to $12 from $13 at BMO Capital
03/27/23 Evercore ISI
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
03/21/23 Piper Sandler
Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
03/03/23 BMO Capital
Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
DEI Douglas Emmett
$12.06 /

+0.485 (+4.19%)

DEI Douglas Emmett
$12.06 /

+0.485 (+4.19%)

Recommendations
Douglas Emmett price target lowered to $12 from $13 at BMO Capital » 16:28
03/29/23
03/29
16:28
03/29/23
16:28
DEI

Douglas Emmett

$12.25 /

+0.485 (+4.12%)

BMO Capital analyst John…

BMO Capital analyst John Kim lowered the firm's price target on Douglas Emmett to $12 from $13 and keeps an Underperform rating on the shares after meeting with management. The firm believes the stock is "inexpensive" and risks of default are "low," but has reduced its 2024 occupancy assumptions and 2024 estimates, noting that 36% of Douglas Emmett's office leases are expiring in 2023-24.

ShowHide Related Items >><<
DEI Douglas Emmett
$12.25 /

+0.485 (+4.12%)

DEI Douglas Emmett
$12.25 /

+0.485 (+4.12%)

03/27/23 Evercore ISI
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI
03/21/23 Piper Sandler
Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
03/03/23 BMO Capital
Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
01/09/23 Credit Suisse
Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
DEI Douglas Emmett
$12.25 /

+0.485 (+4.12%)

DEI Douglas Emmett
$12.25 /

+0.485 (+4.12%)

Recommendations
Douglas Emmett price target lowered to $16 from $17 at Evercore ISI » 09:37
03/27/23
03/27
09:37
03/27/23
09:37
DEI

Douglas Emmett

$11.39 /

+0.545 (+5.03%)

Evercore ISI analyst…

Evercore ISI analyst Steve Sakwa lowered the firm's price target on Douglas Emmett to $16 from $17 and keeps an In Line rating on the shares. Based on Evercore's discussions with investors over the past few weeks, the number one question remains the health of the banking system and the availability of debt. REITs continue to have access to the unsecured bond market, but these institutions are not equipped to take back a significant amount of property, so "pretend and extend" may be "the name of the game," the firm says, adding that most lenders benefited from this method during the Great Financial Crisis. However, the office sector may be an area where this is not the case, as owners may not be willing to throw "good money" after bad as many face higher vacancy rates and cap ex requirements to re-tenant vacant space, Evercore ISI argues. Following the firm's NYC office tour conducted last week, Evercore has reduced its price targets across its office REIT stocks to reflect a more challenging leasing and lending environments.

ShowHide Related Items >><<
DEI Douglas Emmett
$11.39 /

+0.545 (+5.03%)

DEI Douglas Emmett
$11.39 /

+0.545 (+5.03%)

03/21/23 Piper Sandler
Douglas Emmett price target lowered to $13 from $18 at Piper Sandler
03/03/23 BMO Capital
Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
01/09/23 Credit Suisse
Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
01/03/23 Jefferies
Douglas Emmett downgraded at Jefferies on potential for worst case for offices
DEI Douglas Emmett
$11.39 /

+0.545 (+5.03%)

DEI Douglas Emmett
$11.39 /

+0.545 (+5.03%)

Recommendations
Douglas Emmett price target lowered to $13 from $18 at Piper Sandler » 04:54
03/21/23
03/21
04:54
03/21/23
04:54
DEI

Douglas Emmett

$11.57 /

+0.17 (+1.49%)

Piper Sandler analyst…

Piper Sandler analyst Alexander Goldfarb lowered the firm's price target on Douglas Emmett to $13 from $18 and keeps a Neutral rating on the shares. The analyst says fear is driving "depressed valuations" in the office real estate investment trust sector as debt and equity buyers have become adverse to new investment. Sponsorship once again has taken prominence for transactions, while the absence of private equity stepping forward despite what seems like active yields "emphasizes the uncertainty that now exists," the analyst tells investors in a research note.

ShowHide Related Items >><<
DEI Douglas Emmett
$11.57 /

+0.17 (+1.49%)

DEI Douglas Emmett
$11.57 /

+0.17 (+1.49%)

03/03/23 BMO Capital
Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
01/09/23 Credit Suisse
Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
01/03/23 Jefferies
Douglas Emmett downgraded at Jefferies on potential for worst case for offices
01/02/23 Jefferies
Douglas Emmett downgraded to Underperform from Hold at Jefferies
DEI Douglas Emmett
$11.57 /

+0.17 (+1.49%)

DEI Douglas Emmett
$11.57 /

+0.17 (+1.49%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 09:38
03/03/23
03/03
09:38
03/03/23
09:38
CDNA

CareDx

$10.77 /

-5.235 (-32.72%)

, STLA

Stellantis

$18.36 /

+0.1 (+0.55%)

, PG

Procter & Gamble

$139.90 /

+2.26 (+1.64%)

, RDNT

RadNet

$23.83 /

+0.52 (+2.23%)

, BILI

Bilibili

$21.56 /

+1.885 (+9.58%)

, ITRI

Itron

$56.73 /

+1.04 (+1.87%)

, DPZ

Domino's Pizza

$305.27 /

+3.755 (+1.25%)

, VNO

Vornado

$19.62 /

+0.035 (+0.18%)

, DEI

Douglas Emmett

$14.30 /

+0.13 (+0.92%)

, POAHY

Porsche

$5.73 /

+ (+0.00%)

, TTD

Trade Desk

$56.39 /

+1.005 (+1.81%)

, ELVN

Enliven

$23.69 /

+1.46 (+6.57%)

, GOVX

GeoVax Labs

/

+

, NXT

Nextracker

$31.86 /

+0.82 (+2.64%)

, TOWN

TowneBank

$29.87 /

-0.44 (-1.45%)

Want to get stock-moving…

ShowHide Related Items >><<
VNO Vornado
$19.62 /

+0.035 (+0.18%)

TTD Trade Desk
$56.39 /

+1.005 (+1.81%)

TOWN TowneBank
$29.87 /

-0.44 (-1.45%)

STLA Stellantis
$18.36 /

+0.1 (+0.55%)

RDNT RadNet
$23.83 /

+0.52 (+2.23%)

POAHY Porsche
$5.73 /

+ (+0.00%)

PG Procter & Gamble
$139.90 /

+2.26 (+1.64%)

ITRI Itron
$56.73 /

+1.04 (+1.87%)

GOVX GeoVax Labs
/

+

ELVN Enliven
$23.69 /

+1.46 (+6.57%)

DPZ Domino's Pizza
$305.27 /

+3.755 (+1.25%)

DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

CDNA CareDx
$10.77 /

-5.235 (-32.72%)

BILI Bilibili
$21.56 /

+1.885 (+9.58%)

CDNA CareDx
$10.77 /

-5.235 (-32.72%)

03/03/23 Craig-Hallum
CareDx downgraded to Hold at Craig-Hallum after Medicare 'worst case scenario'
03/03/23 Craig-Hallum
CareDx downgraded to Hold from Buy at Craig-Hallum
03/03/23 Raymond James
CareDx double downgraded to Market Perform at Raymond James
03/03/23 Raymond James
CareDx downgraded to Market Perform from Strong Buy at Raymond James
STLA Stellantis
$18.36 /

+0.1 (+0.55%)

03/03/23 RBC Capital
Stellantis upgraded to Outperform from Sector Perform at RBC Capital
02/24/23 RBC Capital
Stellantis price target raised to EUR 19 from EUR 18 at RBC Capital
01/30/23 Berenberg
Stellantis price target lowered to EUR 18 from EUR 19 at Berenberg
01/25/23 Morgan Stanley
Stellantis price target lowered to EUR 18 from EUR 18.50 at Morgan Stanley
PG Procter & Gamble
$139.90 /

+2.26 (+1.64%)

03/03/23 JPMorgan
Procter & Gamble upgraded to Overweight from Neutral at JPMorgan
03/01/23 UBS
Procter & Gamble upgraded to Buy from Neutral at UBS
02/16/23 Citi
Citi launches beverage, personal space with six buys, two sells
02/16/23 Citi
Procter & Gamble initiated with a Buy at Citi
RDNT RadNet
$23.83 /

+0.52 (+2.23%)

03/03/23 Raymond James
RadNet upgraded to Outperform on AI visibility at Raymond James
03/03/23 Raymond James
RadNet upgraded to Outperform from Market Perform at Raymond James
09/29/22 Clarus
Biogen's lecanemab could be positive revenue driver for Akumin, says Clarus
BILI Bilibili
$21.56 /

+1.885 (+9.58%)

03/03/23 Citi
Bilibili upgraded to Buy at Citi with growth seen picking up
03/03/23 Citi
Bilibili upgraded to Buy from Neutral at Citi
12/13/22 Bernstein
Bilibili raised to Market Perform at Bernstein with short case 'less compelling'
12/13/22 Bernstein
Bilibili upgraded to Market Perform from Underperform at Bernstein
ITRI Itron
$56.73 /

+1.04 (+1.87%)

03/03/23 JPMorgan
Itron downgraded to Underweight from Neutral at JPMorgan
02/28/23 Piper Sandler
Itron price target raised to $58 from $48 at Piper Sandler
02/28/23 Baird
Itron price target raised to $52 from $40 at Baird
02/02/23 TD Cowen
Itron price target raised to $72 from $55 at Cowen
DPZ Domino's Pizza
$305.27 /

+3.755 (+1.25%)

03/03/23
Domino's Pizza downgraded at Gordon Haskett on lower long-term growth algorithm
03/03/23
Domino's Pizza downgraded to Hold from Buy at Gordon Haskett
02/28/23 Stifel
Domino's Pizza price target lowered to $300 from $320 at Stifel
02/28/23 Northcoast
Domino's Pizza downgraded to Neutral from Buy at Northcoast
VNO Vornado
$19.62 /

+0.035 (+0.18%)

03/03/23 BMO Capital
Vornado downgraded to Underperform from Market Perform at BMO Capital
01/04/23 Deutsche Bank
Vornado price target lowered to $22 from $25 at Deutsche Bank
01/04/23 Mizuho
Vornado upgraded to Neutral from Underperform at Mizuho
12/14/22 Citi
Vornado downgraded to Sell from Neutral at Citi
DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

03/03/23 BMO Capital
Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital
01/09/23 Credit Suisse
Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
01/03/23 Jefferies
Douglas Emmett downgraded at Jefferies on potential for worst case for offices
01/02/23 Jefferies
Douglas Emmett downgraded to Underperform from Hold at Jefferies
POAHY Porsche
$5.73 /

+ (+0.00%)

03/03/23 HSBC
Porsche downgraded to Hold from Buy at HSBC
01/30/23 Berenberg
Porsche price target raised to EUR 120 from EUR 96.80 at Berenberg
01/25/23 Morgan Stanley
Porsche price target raised to EUR 90 from EUR 82.50 at Morgan Stanley
01/11/23 Exane BNP Paribas
Porsche downgraded to Neutral from Outperform at Exane BNP Paribas
TTD Trade Desk
$56.39 /

+1.005 (+1.81%)

03/03/23 BTIG
Trade Desk initiated with a Neutral at BTIG
02/17/23 Citi
Trade Desk price target raised to $76 from $60 at Citi
02/16/23 Morgan Stanley
Trade Desk price target raised to $58 from $50 at Morgan Stanley
02/16/23 DA Davidson
Trade Desk price target raised to $76 from $56 at DA Davidson
ELVN Enliven
$23.69 /

+1.46 (+6.57%)

03/03/23 TD Cowen
Enliven initiated with an Outperform at TD Cowen
GOVX GeoVax Labs
/

+

03/03/23 Dawson James
GeoVax Labs initiated with a Buy at Dawson James
10/26/22 H.C. Wainwright
GeoVax Labs initiated with a Buy at H.C. Wainwright
05/23/22 Maxim
Maxim sees GeoVax Labs undervalued, citing its MVA vaccine in monkeypox
NXT Nextracker
$31.86 /

+0.82 (+2.64%)

03/03/23 Cantor Fitzgerald
Nextracker initiated with an Overweight at Cantor Fitzgerald
03/03/23 Cantor Fitzgerald
Nextracker initiated with an Overweight at Cantor Fitzgerald
TOWN TowneBank
$29.87 /

-0.44 (-1.45%)

03/03/23 Raymond James
TowneBank resumed with an Outperform at Raymond James
03/03/23 Raymond James
TowneBank initiated with an Outperform at Raymond James
02/17/23 Piper Sandler
TowneBank resumed with an Overweight at Piper Sandler
VNO Vornado
$19.62 /

+0.035 (+0.18%)

TTD Trade Desk
$56.39 /

+1.005 (+1.81%)

TOWN TowneBank
$29.87 /

-0.44 (-1.45%)

STLA Stellantis
$18.36 /

+0.1 (+0.55%)

RDNT RadNet
$23.83 /

+0.52 (+2.23%)

PG Procter & Gamble
$139.90 /

+2.26 (+1.64%)

ITRI Itron
$56.73 /

+1.04 (+1.87%)

DPZ Domino's Pizza
$305.27 /

+3.755 (+1.25%)

DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

CDNA CareDx
$10.77 /

-5.235 (-32.72%)

BILI Bilibili
$21.56 /

+1.885 (+9.58%)

  • 09
    Feb
TTD Trade Desk
$56.39 /

+1.005 (+1.81%)

STLA Stellantis
$18.36 /

+0.1 (+0.55%)

POAHY Porsche
$5.73 /

+ (+0.00%)

PG Procter & Gamble
$139.90 /

+2.26 (+1.64%)

BILI Bilibili
$21.56 /

+1.885 (+9.58%)

TTD Trade Desk
$56.39 /

+1.005 (+1.81%)

STLA Stellantis
$18.36 /

+0.1 (+0.55%)

POAHY Porsche
$5.73 /

+ (+0.00%)

PG Procter & Gamble
$139.90 /

+2.26 (+1.64%)

NXT Nextracker
$31.86 /

+0.82 (+2.64%)

DPZ Domino's Pizza
$305.27 /

+3.755 (+1.25%)

DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

CDNA CareDx
$10.77 /

-5.235 (-32.72%)

BILI Bilibili
$21.56 /

+1.885 (+9.58%)

VNO Vornado
$19.62 /

+0.035 (+0.18%)

TTD Trade Desk
$56.39 /

+1.005 (+1.81%)

STLA Stellantis
$18.36 /

+0.1 (+0.55%)

PG Procter & Gamble
$139.90 /

+2.26 (+1.64%)

ELVN Enliven
$23.69 /

+1.46 (+6.57%)

DPZ Domino's Pizza
$305.27 /

+3.755 (+1.25%)

BILI Bilibili
$21.56 /

+1.885 (+9.58%)

Downgrade
Douglas Emmett downgraded to Underperform from Market Perform at BMO Capital » 05:41
03/03/23
03/03
05:41
03/03/23
05:41
DEI

Douglas Emmett

$14.30 /

+0.13 (+0.92%)

BMO Capital downgraded…

BMO Capital downgraded Douglas Emmett to Underperform from Market Perform with a price target of $13, down from $21. The company's leasing volumes remain elevated but offer no support to leased percent or occupancy where growth remains elusive, the analyst tells investors in a research note. In addition, interest rates remain a headwind and Douglas Emmett "will feel a stronger force" with an additional $437.4M of swaps expiring in 2023 following the $400M that expired in January, contends the firm.

ShowHide Related Items >><<
DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

01/09/23 Credit Suisse
Douglas Emmett downgraded to Neutral from Outperform at Credit Suisse
01/03/23 Jefferies
Douglas Emmett downgraded at Jefferies on potential for worst case for offices
01/02/23 Jefferies
Douglas Emmett downgraded to Underperform from Hold at Jefferies
10/07/22 Piper Sandler
Douglas Emmett downgraded to Neutral from Overweight at Piper Sandler
DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

DEI Douglas Emmett
$14.30 /

+0.13 (+0.92%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.